J Biol Regul Homeost Agents. 2020 Jan-Feb;34(1):111-121. doi: 10.23812/19-315-A.


Mitochondrial and redox dysfunction in post-menopause as risk factor of neurodegenerative disease: a pilot study testing the role of a validated Japanese functional food.

Marotta F1, Marcellino M2, Catanzaro R3, Campiotti A4, Lorenzetti A1, Cervi J1, Barbagallo M5.

Author information

1 ReGenera R&D International for Aging Intervention, Milano, Italy.
2 London Welbeck Hospital, UK.
3 Department of Clinical and Experimental Medicine, Section of Gastroenterology, University of Catania, Catania, Italy.
4 San Babila Clinic, Vitality Therapeutics, CMB Unit, Milano, Italy.
5 Department of Geriatrics and Internal Medicine, University of Palermo, Italy.

Abstract

During the menopause women may experience increased oxidative stress and decreased antioxidant capacity and, together with the decline of neurosteroids, this represents a risk factor for Alzheimer’s disease. The aim of the present study was to test a functional food (FPP-ORI, Osato Research Institute, Gifu, Japan) on redox and mitochondrial efficiency in post-menopausal women. The study population consisting of 69 untreated post-menopausal women were given supplements as follows: Group A was given a multivitamin (MV) 1c 2 times a day, and group B was given FPP 4.5 g 2 times a day. Group C consisted of 23 fertile premenopausal women as the control group. The tests carried out on entry, and at 3 and 6 months were erythrocyte redox parameters, plasma oxidated proteins, brain-derived neurotrophic factor (BDNF) and peripheral blood mononuclear cell (PBMC) mitochondria cytochrome c oxidase Vmax activity. Menopausal women showed an increased malondialdehyde (MDA) (p<0.05 vs control) which was normalized by both treatments (p<0.05), but MV failed to do so in the BMI ≥26 subgroup (p<0.05). All other redox enzymes and BDNF were significantly lower in menopausal women and they responded only to FPP (p<0.05). Carbonyl protein level was higher in “BMI ≥ 26” subgroup (p<0.05) and reduced only by FPP (p<0.05). The PBMC cyclooxygenase to citrate synthase activity was reduced (<40%) in the menopausal group (p<0.01) and only FPP caused a significant restoration (p<0.05). Although preliminary, these data confirm the redox and mitochondrial dysfunction occurring in post-menopause and responsive to FPP but very poorly to high dosage antioxidants. This may lead to potential preventive opportunities in menopause-associated neurodegenerative disease.

KEYWORDS:

BDNF, COX activity, FPP-ORI, GPx, MDA, SOD1, menopause, mitochondria, redox dysfunction

Publication type

  • Journal Article

You may also like...